Edition:
United Kingdom

Santen Pharmaceutical Co Ltd (4536.T)

4536.T on Tokyo Stock Exchange

1,771JPY
20 Nov 2017
Change (% chg)

¥-21 (-1.17%)
Prev Close
¥1,792
Open
¥1,789
Day's High
¥1,805
Day's Low
¥1,765
Volume
1,350,900
Avg. Vol
1,174,437
52-wk High
¥1,838
52-wk Low
¥1,251

Summary

Name Age Since Current Position

Akira Kurokawa

64 2008 President, Chief Executive Officer, Representative Director

Kazuo Koshiji

2017 Chief Financial Officer, Managing Executive Officer, Chief Director of Finance

Noriaki Yamamoto

Chief Information Officer, Executive Officer, Chief Director of Information System

Naveed Shams

2017 Chief Scientific Officer, Managing Executive Officer, Chief Director of Research & Development

Masamichi Sato

2017 Managing Executive Officer, Chief Compliance Officer, Chief Director of CSR & Internal Control, President of Subsidiary

Takeshi Ito

58 2017 Senior Managing Executive Officer, Director of Pharmaceutical Business, Director

Akihiro Tsujimura

49 2017 Senior Managing Executive Officer, Director of Asia Business, President & Chief Executive Officer of Subsidiary, Director

Shigeo Taniuchi

43 2017 Managing Executive Officer, President of Subsidiary, Director

Atsutoshi Ohta

Managing Executive Officer, Chief Director of Human Resources & Organization Development

Takahiro Morita

2017 Executive Officer, Senior Director of Pharmaceutical Sales in Pharmaceutical Business Unit

Akio Kimura

2017 Executive Officer, Chief Director of Product Supply, Chief Director of Reliability Guarantee

Ye Liu

Executive Officer, General Manager of Subsidiary

Kenji Morishima

2016 Executive Officer, Senior Director of Pharmaceutical Technology in Main Research & Development Unit

Satoshi Suzuki

2017 Executive Officer, Chief Director of Planning

Takayuki Katayama

71 2012 Independent Director

Kanoko Ohishi

56 2015 Independent Director

Yutaro Shintaku

61 2017 Independent Director

Hidetaka Mizutani

2017 Manager of Finance & Accounting Group

Biographies

Name Description

Akira Kurokawa

Mr. Akira Kurokawa has been serving as President, Chief Executive Officer and Representative Director in Santen Pharmaceutical Co., Ltd. since June 25, 2008. He joined the Company in April 1977. His previous titles include Director of Pharmaceutical Business, Executive Officer, Managing Executive Officer and Chief Operating Officer in the Company. He used to serve as President and Director in a subsidiary, Santen Holdings U.S. Inc.

Kazuo Koshiji

Noriaki Yamamoto

Naveed Shams

Masamichi Sato

Takeshi Ito

Mr. Takeshi Ito has been serving as Senior Managing Executive Officer, Director of Pharmaceutical Business and Director in Santen Pharmaceutical Co., Ltd. since June 23, 2017. He joined the Company in April 1982. His previous titles include Executive Officer, Managing Executive Officer, Manager of Business Development Office in Main Business Development Unit, Manager of Planning Office in Research & Development Strategy Supervisor Unit, Director of Surgical Business, Senior Director of Research & Development in Main Research & Development Unit and Senior Director of Pharmaceutical Sales in Pharmaceutical Business Unit in the Company.

Akihiro Tsujimura

Mr. Akihiro Tsujimura has been serving as Senior Managing Executive Officer, Director of Asia Business and Director in Santen Pharmaceutical Co., Ltd., as well as President and Chief Executive Officer of a subsidiary, Santen Inc., since June 23, 2017. He joined the Company in August 2004. His previous titles include Executive Officer, Managing Executive Officer, Director of Business Development and Chief Director of Planning in the Company.

Shigeo Taniuchi

Mr. Shigeo Taniuchi has been serving as Managing Executive Officer and Director in Santen Pharmaceutical Co., Ltd., as well as President of a subsidiary, Santen Holdings EU B. V., since June 23, 2017. He joined the Company in April 1996. His previous titles include Executive Officer, Assistant Manager of China Business Supervisor Office in Asia Business Unit, Manager of Business Planning & Administration Office in Asia Business Unit, Manager of Business Planning Office in Main Planning Unit and Deputy Chief Director of Planning in the Company.

Atsutoshi Ohta

Takahiro Morita

Akio Kimura

Ye Liu

Kenji Morishima

Satoshi Suzuki

Takayuki Katayama

Mr. Takayuki Katayama has been serving as Independent Director in Santen Pharmaceutical Co., Ltd. since June 2012. He is also serving as Independent Director in Olympus Corporation, and working for Teijin Limited. He used to work for Toyo Seikan Group Holdings, Ltd.

Kanoko Ohishi

Ms. Kanoko Ohishi has been serving as Independent Director in Santen Pharmaceutical Co., Ltd. since June 2015. She is also serving as Independent Director in Ezaki Glico Company, Limited, Suruga Bank Ltd. and Shiseido Company, Limited, as well as Representative Director in Mediva Inc. and another company, and working for Plata-net. She used to work for McKinsey & Company, Inc. and Astellas Pharma Inc.

Yutaro Shintaku

Mr. Yutaro Shintaku has been serving as Independent Director in Santen Pharmaceutical Co., Ltd. since June 2017. He is also serving as Director in TERUMO CORPORATION.

Hidetaka Mizutani